Back to Dashboard
USNA · Consumer Defensive

Usana Health Sciences Inc

USA Consumer Defensive Filing: 2026-03-31
24/100
Smart-money confidence1 of 3 sources positive
Bearish — money moving out

No standout activity across the feeds we track.

Hedge funds
32
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$247M
Industry
Packaged Foods
Sector
Consumer Defensive
Exchange
NYSE
About USANA HEALTH SCIENCES INC

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other…

Who's behind the signal
Every informed buyer we can see on USNA, across all three feeds.
Hedge funds · 6
Point72 (Steve Cohen) New position
AQR Capital Management Increased +427%
D.E. Shaw & Co Decreased −10%
Citadel Advisors Decreased −73%
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. USANA HEALTH SCIENCES INC isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
1
New positions
1
Increasing
4
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
New position
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
Trust weight: 1.0×
Increased +427%
% of portfolio
0.0%
Position change
+427%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.2×
Decreased −36%
% of portfolio
0.0%
Position change
−36%
0.0% of Tudor Investment's portfolio
Trust weight: 1.0×
Decreased −10%
% of portfolio
0.0%
Position change
−10%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
Decreased −73%
% of portfolio
0.0%
Position change
−73%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
Decreased −67%
% of portfolio
0.0%
Position change
−67%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to USANA HEALTH SCIENCES INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell USANA HEALTH SCIENCES INC or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费,直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订